Business
Pfizer to supply 40 million shots for poor countries – Sydney Morning Herald
The deal is a boost to the global program known as COVAX, as wealthy nations have snapped up most of the millions of coming shots.
Pfizers 40 million doses for a vaccine requiring two doses are a tiny sliver of whats needed for COVAX, which aims to vaccinate billions of people in 92 low- and middle-income countries.
During Fridays news conference, Tedros said Pfizers commitment and about 150 million doses of the vaccine developed by AstraZeneca and Oxford University could enable COVAX to begin delivering doses in February, pending finalisation of a supply agreement with Pfizer and emergency use approval for AstraZenecas vaccine….
-
Noosa News21 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference
-
Business21 hours agoDicker Data rides the AI trend to double digit growth
-
Business24 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy
-
Noosa News21 hours agoBob Katter threatens Channel 9 journalist for asking question on family heritage